Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
Overview
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics is a scientific journal, published since 2004 in English. The journal's country of origin is United States and its primary focus area is neurology.
Details
Details
Abbr.
NeuroRx
Start
2004
End
2006
Frequency
Quarterly
p-ISSN
1545-5343
e-ISSN
1545-5351
Country
United States
Language
English
Specialty
Neurology
Recent Articles
1.
2.
3.
4.
Chard S
NeuroRx
. 2006 Oct;
3(4):525-34.
PMID: 17012066
Over the past decade, community neurorehabilitation has emerged as a promising extension of neurological rehabilitation. The goal of community neurorehabilitation is to maximize functional ability and quality of life through...
5.
Barak S, Duncan P
NeuroRx
. 2006 Oct;
3(4):505-24.
PMID: 17012065
Most patients who survive a stroke experience some degree of physical recovery. Selecting the appropriate outcome measure to assess physical recovery is a difficult task, given the heterogeneity of stroke...
6.
Schallert T
NeuroRx
. 2006 Oct;
3(4):497-504.
PMID: 17012064
Select functional outcome tests commonly used for evaluating sensorimotor and cognitive capacity in rodents with focal intracerebral ischemic or hemorrhagic injury are described, along with upgrades and issues of concern...
7.
Grutzendler J, Gan W
NeuroRx
. 2006 Oct;
3(4):489-96.
PMID: 17012063
Two-photon microscopy (TPM) has become an increasingly important tool for imaging the structure and function of brain cells in living animals. TPM imaging studies of neuronal structures over intervals ranging...
8.
Yozbatiran N, Cramer S
NeuroRx
. 2006 Oct;
3(4):482-8.
PMID: 17012062
Most patients show improvement in the weeks or months after a stroke. Recovery is incomplete, however, leaving most with significant impairment and disability. Because the brain does not grow back...
9.
Webster B, Celnik P, Cohen L
NeuroRx
. 2006 Oct;
3(4):474-81.
PMID: 17012061
Stroke is a common disorder that produces a major burden to society, largely through long-lasting motor disability in survivors. Recent studies have broadened our understanding of the processes underlying recovery...
10.
Chen J, Chopp M
NeuroRx
. 2006 Oct;
3(4):466-73.
PMID: 17012060
There is a compelling need to develop cell and pharmacological therapeutic approaches to be administered beyond the hyperacute phase of stroke. These therapies capitalize on the capacity of the brain...